{"id":7851,"date":"2026-03-01T22:16:34","date_gmt":"2026-03-01T22:16:34","guid":{"rendered":"https:\/\/live-cancer-factfinder.pantheonsite.io\/fact-finder-tool\/asenik-lakoz-kanse-cheche-enfomasyon-sou-kanse\/"},"modified":"2026-10-20T16:55:45","modified_gmt":"2026-10-20T16:55:45","slug":"asenik-lakoz-kanse-cheche-enfomasyon-sou-kanse","status":"publish","type":"post","link":"https:\/\/cancerfactfinder.org\/ht\/zouti-pou-cheche-enfomasyon\/asenik-lakoz-kanse-cheche-enfomasyon-sou-kanse\/","title":{"rendered":"AFIKASYON: Asenik lak\u00f2z kans\u00e8"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Sa ou ka tande<\/h2>\n\n<p class=\"wp-block-paragraph\">Moun souvan enkyete ke ekspozisyon nan asenik, sitou atrav\u00e8 dlo potab ki kontamine, ka lak\u00f2z kans\u00e8. Enkyetid sa a soti nan etid ki montre pi gwo pousantaj kans\u00e8 nan z\u00f2n ki gen gwo nivo asenik. <\/p>\n\n<h2 class=\"wp-block-heading\">Sa syans di nou<\/h2>\n\n<p class=\"wp-block-paragraph\">Konpoze asenik in\u00f2ganik yo, tankou sa yo jwenn nan dlo ki kontamine ak nan anviw\u00f2nman okipasyon\u00e8l, klase pa IARC k\u00f2m kanseroj\u00e8n Gwoup 1, ki vle di gen ase pr\u00e8v ki montre yo lak\u00f2z kans\u00e8 nan moun. Gwo ajans tankou Ajans Pwoteksyon Anviw\u00f2nman Etazini (EPA), Pwogram Toksikoloji Nasyonal (NTP), ak Enstiti Nasyonal Kans\u00e8 (NCI) rekon\u00e8t asenik k\u00f2m kanseroj\u00e8n tou, ki baze sou done solid sou moun ( <a href=\"https:\/\/www.cancer.org\/cancer\/risk-prevention\/chemicals\/arsenic.html\" target=\"_blank\" rel=\"noopener\">ACS<\/a> ) ( <a href=\"https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Arsenic-Metals-Fibres-And-Dusts-2012\" target=\"_blank\" rel=\"noopener\">IARC<\/a> ). <\/p>\n\n<h3 class=\"wp-block-heading\">Pr\u00e8v Epidemyolojik<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>Etid sou gwo ech\u00e8l sou moun montre toujou ke konsomasyon dlo ki kontamine ak asenik alont\u00e8m asosye av\u00e8k yon ogmantasyon risk pou kans\u00e8 po, nan blad pipi ak nan poumon. Ch\u00e8ch\u00e8 nan Banglad\u00e8ch ak Taiwan rap\u00f2te relasyon d\u00f2z-repons solid; pa egzanp, vilaj Taiwan\u00e8 ki gen dlo pi wo pase 10 \u00b5g\/L te gen to kans\u00e8 nan blad pipi ki te ogmante anpil, pafwa ak risk ki te double oswa plis. ( <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24889821\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a> )<\/li>\n\n\n\n<li>Nan anviw\u00f2nman pwofesyon\u00e8l, tankou min\u00e8 f\u00e8blan nan Lachin ki ekspoze a asenik nan l\u00e8 a, risk kans\u00e8 nan poumon te dramatikman pi wo, jiska 20 fwa, pami travay\u00e8 ki te ekspoze alont\u00e8m. ( <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28915699\/\" target=\"_blank\" rel=\"noopener\">PubMed<\/a> )<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Pr\u00e8v Laboratwa \/ Sip\u00f2  <\/h3>\n\n<p class=\"wp-block-paragraph\">Etid sou b\u00e8t ak mekanistik yo sip\u00f2te done imen yo. Ekspozisyon asenik in\u00f2ganik nan wonj\u00e8 lak\u00f2z kans\u00e8 nan po, nan blad pipi, ak nan apar\u00e8y urin, sitou l\u00e8 yo konbine av\u00e8k l\u00f2t kanseroj\u00e8n. Li konnen tou ke asenik ent\u00e8fere ak reparasyon ADN epi li ankouraje estr\u00e8s oksidatif, ki se mekanis kle nan kanseroj\u00e8n\u00e8z. ( <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK570318\/\" target=\"_blank\" rel=\"noopener\">NLM<\/a> )<\/p>\n\n<h3 class=\"wp-block-heading\">Klasifikasyon Kanseroj\u00e8n IARC<\/h3>\n\n<p class=\"wp-block-paragraph\">IARC klase asenik ak konpoze asenik in\u00f2ganik k\u00f2m Gwoup 1 &#8211; Kanseroj\u00e8n pou moun ki baze sou pr\u00e8v ase ki soti nan etid sou moun ak b\u00e8t. Sa gen ladan kans\u00e8 nan poumon, nan blad pipi ak nan po, ak pr\u00e8v limite pou kans\u00e8 nan fwa, nan ren ak nan pwostat ( <a href=\"https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Arsenic-Metals-Fibres-And-Dusts-2012\" target=\"_blank\" rel=\"noopener\">IARC<\/a> ). <\/p>\n\n<h2 class=\"wp-block-heading\">Kijan pou diminye risk ou<\/h2>\n\n<ul class=\"wp-block-list\">\n<li>Moun yo ta dwe teste pi prive yo epi s\u00e8vi ak sist\u00e8m tretman oswa dlo nan bout\u00e8y si nivo asenik la depase estanda sekirite yo tankou 10 \u00b5g\/L, ki se gid Etazini an.  <\/li>\n\n\n\n<li>Ajans regilasyon yo ak defans\u00e8 sante piblik yo ta dwe bay priyorite a aks\u00e8 a dlo pw\u00f2p nan z\u00f2n ki afekte yo. Pwoteksyon okipasyon\u00e8l tankou pwoteksyon respiratwa ak limit ekspozisyon yo esansy\u00e8l tou.   <\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">Liy final la<\/h2>\n\n<p class=\"wp-block-paragraph\">Gen pr\u00e8v kl\u00e8 ak konsistan ki montre asenik in\u00f2ganik lak\u00f2z kans\u00e8 lakay moun, patikily\u00e8man nan po, nan blad pipi ak nan poumon. Kontwole ekspozisyon, sitou nan dlo potab, se yon priyorite sante piblik enp\u00f2tan. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sa ou ka tande Moun souvan enkyete ke ekspozisyon nan asenik, sitou atrav\u00e8 dlo potab ki kontamine, ka lak\u00f2z kans\u00e8. Enkyetid sa a soti nan etid ki montre pi gwo pousantaj kans\u00e8 nan z\u00f2n ki gen gwo nivo asenik. Sa syans di nou Konpoze asenik in\u00f2ganik yo, tankou sa yo jwenn nan dlo ki kontamine&hellip;<\/p>\n","protected":false},"author":9,"featured_media":7853,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[545],"tags":[472],"class_list":["post-7851","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-rejim-alimante-ak-nitrisyon","tag-definitivman-oswa-pwobableman-vre"],"acf":[],"_links":{"self":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/comments?post=7851"}],"version-history":[{"count":6,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7851\/revisions"}],"predecessor-version":[{"id":18142,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7851\/revisions\/18142"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media\/7853"}],"wp:attachment":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media?parent=7851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/categories?post=7851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/tags?post=7851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}